BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takaki S, Fukuhara T, Mori N, Tsuji K. High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma. Mol Clin Oncol 2020;12:60-8. [PMID: 31814977 DOI: 10.3892/mco.2019.1949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fabritius MP, Seidensticker M, Rueckel J, Heinze C, Pech M, Paprottka KJ, Paprottka PM, Topalis J, Bender A, Ricke J, Mittermeier A, Ingrisch M. Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer. J Clin Med 2021;10:3668. [PMID: 34441964 DOI: 10.3390/jcm10163668] [Reference Citation Analysis]
2 Suk FM, Wang YH, Chiu WC, Liu CF, Wu CY, Chen TL, Liao YJ. Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:8567. [PMID: 34445279 DOI: 10.3390/ijms22168567] [Reference Citation Analysis]
3 Labadie KP, Sham JG. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody. Ann Surg Oncol 2020;27:4070-2. [PMID: 32529273 DOI: 10.1245/s10434-020-08702-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hirokawa F, Komeda K, Taniguchi K, Asakuma M, Shimizu T, Inoue Y, Kagota S, Tomioka A, Yamamoto K, Uchiyama K. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial. Ann Surg Oncol 2020;27:4143-52. [PMID: 32500344 DOI: 10.1245/s10434-020-08699-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]